亚美尼亚2020-2021年呼吸道疾病门诊与住院成本及季节性流感疫苗接种项目成本
该研究从社会视角测量了亚美尼亚流感和流感疫苗接种项目的成本。2022年12月至2023年3月通过结构化问卷在15家医疗机构回顾性收集成本数据。SARI和ILI病例每次平均成本分别为823.6美元和616.57美元;2021-2022流感季疫苗接种项目政府总成本为4,353,738美元,每剂接种总成本25.61美元。
要点
- SARI病例每次平均成本823.6美元,ILI病例每次平均成本616.57美元。
- 2021-2022流感季疫苗接种项目政府总成本4,353,738美元。
- 每剂接种总成本25.61美元,其中采购成本每剂7.73美元。
核心结论
- 这些关于亚美尼亚季节性流感预防项目成本和流感疾病社会成本的数据可为亚美尼亚国家疫苗政策决策提供信息,并可能对其他中等收入国家有用。
- 流感疫苗与其他疫苗项目一样,被认为对减轻疾病负担和相关死亡率及进一步推动经济增长有实质性贡献。
- 然而,一旦获得疾病负担数据,应进行正式的成本效果分析。
研究设计与样本
- 研究从社会视角测量亚美尼亚流感和流感疫苗接种项目的成本。
- 2022年12月至2023年3月期间,通过结构化问卷从病例患者和医疗服务提供者处回顾性收集成本数据,覆盖通过分层抽样选出的15家医疗机构。
- 医疗成本包括药物、实验室成本、实验室和诊断检测以及常规卫生服务成本,并包括直接和间接社会成本。
- 2021-2022流感季的疫苗接种项目成本通过会计记录识别,分类为:规划、分发、培训、社会动员和外展、监督和监测、采购以及国家和机构层面行政管理和储存。
主要发现
- SARI和ILI病例每次平均成本分别为823.6美元和616.57美元。
- 卫生服务成本是ILI和SARI病例患者最大的直接支出。
- 2021-2022流感疫苗接种项目政府总成本为4,353,738美元,最大成本与国家和机构层面行政管理和储存相关(分别为30%和65%)。
- 每剂接种总成本为25.61美元(采购每剂7.73美元,边际管理成本每剂17.88美元)。
临床怎么用
- 这些数据可为亚美尼亚国家疫苗政策决策提供信息,并可能对其他中等收入国家有用。
- 一旦获得疾病负担数据,应进行正式的成本效果分析。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the substantial global impact of influenza, there are limited economic data to guide influenza vaccination programs investments in middle-income countries. We measured the costs of influenza and the costs of an influenza vaccination program in Armenia, using a societal perspective. METHODS: During December 2022 through March 2023, retrospective cost data were collected from case-patients and healthcare providers through structured questionnaires at 15 healthcare facilities selected through stratified sampling. Medical costs included medications, laboratory costs, laboratory and diagnostic tests, and routine health care service costs and direct and indirect societal costs were included. Vaccination program costs from the 2021-2022 influenza season were identified using accounting records and categorized as: planning, distribution, training, social mobilization and outreach, supervision and monitoring, procurement, and national- and facility-level administration and storage. RESULTS: The mean costs per episode for SARI and ILI case-patients were $US 823.6 and $US 616.57, respectively. Healthcare service costs were the largest direct expenses for ILI and SARI case-patients. Total costs of the 2021-2022 influenza vaccination program to the government were $US 4,353,738, with the largest costs associated with national- and facility-level administration and storage (30% and 65% respectively). The total cost per dose administered was $US 25.61 ($US 7.73 per dose for procurement and $US 17.88 for the marginal administration cost per dose). CONCLUSIONS: These data on the costs of seasonal influenza prevention programs and the societal costs of influenza illness in Armenia may inform national vaccine policy decisions in Armenia and may be useful for other middle-income countries. Influenza vaccines, like other vaccine programs, are recognized as substantially contributing to the reduction disease burden and associated mortality and further driving economic growth. However, a formal cost-effectiveness analysis should be performed once burden of disease data are available.
引用
- Gobin S, Sahakyan G, Kusi Appiah M, et al. Costs of in- and outpatient respiratory disease and the seasonal influenza vaccination program in Armenia - 2020-2021. Vaccine. 2024. PMID: 38839517. doi:10.1016/j.vaccine.2024.05.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。